Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53

US7115729B2 · kind B2 · utility

Assignees

• Cornell Research Foundation, Inc. · US
• LUDWIG INSTITUTE FOR CANCER RESEARCH LTD · GB
• Memorial Sloan Kettering Cancer Center · US

Inventors

• Alexander Knuth · Frankfurt am Main, DE
• Elke Jager · Frankfurt am Main, DE
• Yao-Tseng Chen · New York, US
• Matthew Scanlan · Princeton Junction, US
• Ali Gure · New York, US
• Gerd Ritter · New York, US
• Lloyd J. Old · New York, US
• Jan Wouter Drijfhout · Leiden, NL

Key dates

• Filing date: Jan 2, 2004
• Grant date: Oct 3, 2006
• Expiry date: Jul 24, 2024

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K39/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to peptides which bind to MHC Class I and to MHC Class II molecules. These peptides are useful in different therapeutic and diagnostic contexts.